ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ATIF MIAN MD

Internal Medicine

18,587

$965K

560
467 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

WILLIAM ELLEDGE M.D.

Internal Medicine

2,044

$83.2K

117
97 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $56

BRADLEY SCHMITZ MD

Internal Medicine

12,822

$758K

519
439 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

DENNIS KIM M.D.

Internal Medicine

24,481

$1.5M

669
513 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

YAJUN LIU

Internal Medicine

3,843

$253K

149
85 are 65+

28%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

NANCY LLEWELLYN M.D.

Internal Medicine

4,151

$150K

174
157 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $56

LESTER SAUVAGE MD

Internal Medicine

18,144

$826K

515
489 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JENNIFER AZEN M.D., M.P.H.

Internal Medicine

7,115

$440K

301
172 are 65+

25%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

DIANE DOERNER MD

Internal Medicine

6,964

$369K

250
186 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

JOSEPH REGIMBAL M.D.

Internal Medicine

13,640

$815K

455
312 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

ALLISON HINZ MD

Internal Medicine

1,187

$49.6K

89
54 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

MARK THORSON MD

Internal Medicine

9,705

$508K

414
365 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

PATRICIA PETERSON MD

Internal Medicine

13,183

$627K

693
553 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

STEWART BIRSE MD

Internal Medicine

13,550

$643K

537
450 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

CLAUDIU-GILY IONESCU-TAJTI M.D.

Internal Medicine

8,051

$412K

284
198 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

LARRY MCKNIGHT M.D.

Internal Medicine

813

$41.9K

189
155 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

DENNIS MOUNTJOY MD

Internal Medicine

7,566

$485K

225
190 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

GITTLE GOODMAN WILSON MD

Internal Medicine

3,913

$374K

177
136 are 65+

22%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $56

GRETCHEN POTSCHKA MD

Internal Medicine

7,560

$388K

243
157 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

SANJIT DUTTA MD

Internal Medicine

13,429

$614K

645
527 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

ANDREW PERRY MD

Internal Medicine

4,778

$265K

184
66 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

MYTHILI RAMACHANDRAN M.D.

Internal Medicine

9,940

$491K

338
265 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

JOSE NESS MD

Internal Medicine

1,187

$236K

125
109 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 23%

$199
Average prescription price

Avg: $56

MAJA ZUGEC MD

Internal Medicine

7,785

$419K

311
231 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

SEAN HURLEY MD

Internal Medicine

6,893

$344K

311
277 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank